Skip to main contentAll experts

Rajesh Khanna

AST DEAN & PROF

MD-PHARMACOLOGY - THERAPEUTICS

Orcid identifier0000-0002-9066-2969 (opens in a new tab)⁠
  • AST DEAN & PROF
    MD-PHARMACOLOGY - THERAPEUTICS

GRANTS

  • GRANT
    Validation of Neuropilin-1 Receptor Signaling in Nociceptive Processing
    National Institute of Health Ninds8 Sep 2026 - 31 Aug 2028
    Active
  • GRANT
    Fibronectin Modulation of Oral Cancer Nociception
    National Institute of Health Nidcr18 Mar 2026 - 20 Aug 2027
    Active
  • GRANT
    Dissection of NTSR2/calcium channel signaling as a non-opioid spinal analgesic mechanism for the treatment of high impact chronic pain
    National Institute of Health Ninds17 Apr 2025 - 30 Nov 2029
    Active
  • GRANT
    Chicago Center on Musculoskeletal Pain (C-COMP Pilot Award: Mouse Achilles Tendinopathy Pain Behavior Assessments)
    National Institute of Health Niams1 Jan 2025 - 31 Dec 2025
    Expired
  • GRANT
    Targeting CRMP2-Nav1.7 and Cav2.2 interaction for fibromyalgia treatment
    Pharma Research and Manufacturers of America1 Jan 2025 - 31 Dec 2026
    Active
  • GRANT
    Targeting Schwann cell dysfunction and repair signaling in chemotherapy induced painful peripheral neuropathy
    National Institute of Health Nidcr20 Sep 2024 - 31 Aug 2027
    Active
  • GRANT
    Validation of Neuropilin-1 Receptor Signaling in Nociceptive Processing
    National Institute of Health Ninds5 Sep 2024 - 31 Aug 2026
    Expired
  • GRANT
    Validation of a Nonopioid Analgesic Pathway in Human Sensory Ganglia and Spinal Cord
    US Army Med Research Acquisition30 Aug 2024 - 14 Sep 2028
    Active
  • GRANT
    Neuropeptide Y1 Receptor-Expressing Neurons in the Lateral Parabrachial Nucleus in Neuropathic Pain
    National Institute of Health Ninds16 Aug 2024 - 31 Mar 2026
    Expired
  • GRANT
    Antagonists of CRMP2 Phosphorylation for Chemotherapy-Induced Peripheral Neuropathy
    National Institute of Health Ninds12 Aug 2024 - 31 Aug 2026
    Expired
  • GRANT
    Genetic and Pharmacological Validation of CRMP2 Phosphorylation as a Novel therapeutic Target for Neuropathic Pain
    National Institute of Health Ninds19 Jul 2024 - 31 Jul 2025
    Expired
  • GRANT
    Lymphocyte Antigen 6 (Ly6) Proteins: New Players in Chronic Pain
    7 Jun 2024 - 31 Aug 2025
    Active
  • GRANT
    Validation of Spinal Neurotensin Receptor 2 as an Analgesic Target
    National Institute of Health Ninds15 May 2024 - 31 Aug 2025
    Expired
  • GRANT
    Endosomal mechanisms signaling oral cancer pain
    National Institute of Health Nidcr14 Mar 2024 - 31 Aug 2026
    Expired